Athira Pharma Inc (ATHA)
2.71
+0.50
(+22.62%)
USD |
NASDAQ |
May 16, 16:00
2.73
+0.02
(+0.74%)
After-Hours: 20:00
Athira Pharma Total Assets (Quarterly): 160.24M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 160.24M |
| September 30, 2023 | 184.70M |
| June 30, 2023 | 208.05M |
| March 31, 2023 | 232.77M |
| December 31, 2022 | 258.15M |
| September 30, 2022 | 274.18M |
| June 30, 2022 | 292.01M |
| March 31, 2022 | 313.00M |
| Date | Value |
|---|---|
| December 31, 2021 | 332.01M |
| September 30, 2021 | 347.33M |
| June 30, 2021 | 360.12M |
| March 31, 2021 | 369.41M |
| December 31, 2020 | 279.56M |
| September 30, 2020 | 267.94M |
| June 30, 2020 | 85.43M |
| December 31, 2019 | 2.189M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
2.189M
Minimum
Dec 2019
369.41M
Maximum
Mar 2021
247.94M
Average
271.06M
Median
Total Assets (Quarterly) Benchmarks
| Xeris Biopharma Holdings Inc | 336.62M |
| Kodiak Sciences Inc | 479.37M |
| Phathom Pharmaceuticals Inc | 356.50M |
| Arcutis Biotherapeutics Inc | 478.54M |
| Inozyme Pharma Inc | 176.94M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 30.06M |
| Shareholders Equity (Quarterly) | 130.19M |